Tvardi Therapeutics (TVRD) Stock Chart & Stock Price History $6.69 -34.91 (-83.92%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tvardi Therapeutics Stock Price Performance The Tvardi Therapeutics (TVRD) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 80.25%, reflecting recent market activity. As of the latest close, Tvardi Therapeutics traded at $41.60 with a market cap of $390.08 million and volume of 83,509 shares. Receive TVRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-83.24%1 Month Performance-80.25%3 Month Performance-75.53% TVRD Stock Chart for Monday, October, 13, 2025 TVRD Chart by TradingView Tvardi Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/10/2025$42.98$41.60-3.21%$43.65$41.0083,509 shs$390.08 million10/09/2025$39.91$42.98+7.69%$43.34$39.8850,417 shs$403.15 million10/08/2025$40.28$39.91-0.92%$40.52$39.1333,194 shs$374.36 million10/07/2025$40.18$40.28+0.25%$41.67$39.1639,157 shs$377.71 million10/06/2025$40.23$40.18-0.12%$42.10$39.6937,351 shs$376.89 million10/03/2025$37.37$40.23+7.65%$41.00$37.9458,178 shs$377.36 million10/02/2025$37.82$37.37-1.19%$39.48$36.0539,418 shs$350.53 million10/01/2025$38.97$37.82-2.95%$39.69$37.2540,125 shs$354.64 million09/30/2025$36.90$38.97+5.61%$39.80$35.46185,486 shs$365.54 million09/29/2025$36.32$36.90+1.60%$38.15$34.6643,903 shs$346.12 million Get the Latest News and Ratings for TVRD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/26/2025$36.81$36.32-1.33%$38.28$35.1544,448 shs$340.68 million09/25/2025$37.03$36.81-0.59%$38.50$35.91110,704 shs$345.17 million09/24/2025$37.46$37.03-1.15%$39.69$37.0378,776 shs$347.34 million09/23/2025$37.40$37.46+0.16%$38.92$35.8650,248 shs$351.38 million09/22/2025$38.24$37.40-2.20%$37.60$35.2737,984 shs$350.70 million09/19/2025$38.74$38.24-1.29%$39.71$36.99245,923 shs$358.58 million09/18/2025$39.04$38.74-0.77%$40.77$37.7076,536 shs$363.38 million09/17/2025$33.83$39.04+15.40%$39.04$34.16134,790 shs$366.20 million09/16/2025$33.76$33.83+0.21%$35.20$33.5132,459 shs$317.22 million09/15/2025$33.88$33.76-0.35%$35.39$33.6023,559 shs$316.67 million09/12/2025$35.40$33.88-4.29%$36.71$33.2239,705 shs$317.79 million Related Companies Janux Therapeutics Stock Price Chart LENZ Therapeutics Stock Price Chart Stoke Therapeutics Stock Price Chart Xeris Biopharma Stock Price Chart Syndax Pharmaceuticals Stock Price Chart Taysha Gene Therapies Stock Price Chart Sionna Therapeutics Stock Price Chart Zymeworks Stock Price Chart Nuvation Bio Stock Price Chart Ardelyx Stock Price Chart Receive TVRD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TVRD) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tvardi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tvardi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
